Kübler Alexander C, Stenzel W, Rühling M, Meul B, Fischer J-H
Department of Craniomaxillofacial and Plastic Surgery, University of Cologne, Kerpenerstrasse 62, 50937 Cologne, Germany.
Lasers Surg Med. 2003;33(4):247-55. doi: 10.1002/lsm.10220.
Tumours of the head and neck show a high local tumour recurrence rate ranging between 7 and 30% despite combined treatment modalities. To improve these data, photodynamic therapy (PDT) might be used as an additional treatment besides surgery and radio-chemotherapy. Intra-operative PDT has been proposed to "sterilise" the tumour bed after surgical tumour resection in order to kill any remaining tumour cells which are responsible for local tumour recurrences. Often, during head and neck surgery, large blood vessels and important nerve structures are exposed and could potentially be harmed by intra-operative PDT. Despite the fact that mTHPC is the most commonly used photosensitiser for head and neck tumours, there are no data on potential detrimental side effects of intra-operative PDT onto these vital structures. The purpose of this study was to use a maximal treatment protocol in rabbit observing possible damage to the blood vessels and nerve structures and thus judge the most severe event that could happen in patients.
STUDY DESIGN/MATERIALS AND METHODS: In rabbits the large blood vessels and nerve structures at the neck and at the groin area were surgically exposed and treated by mTHPC-mediated intra-operative PDT. Various treatment parameters (drug-light interval, light dosage, follow up interval) were modified in order to find the critical treatment parameters which might cause maximum tissue effects. The intention was to define the most severe clinical complications which could be expected from mTHPC mediated intra-operative PDT.
The most severe tissue reactions were found at a drug dosage of 0.3 mg/kg, a drug-light interval of 24 hours and a light dosage of 20 J/cm(2). Complete necrosis was found for the muscles, fat and connective tissue within the entire treatment field. Blood vessels demonstrated severe oedema, media-hyperplasia or loosening of the endothelial layer leading to various degrees of local thrombosis but no break down of the vessel wall or any rupture was noted. Most nerves were altered by a 75% demyelisation but this did not result in any clinical symptoms.
Our results have shown that mTHPC mediated intra-operative PDT used with a maximal treatment protocol (very high doses and very short drug-light intervals) has significant histological impact onto all tissue structures, but did not show any clinical symptoms in rabbits. mTHPC mediated intra-operative PDT seems to be a promising and a safe treatment option which could complement existing treatment modalities in order to improve total survival rate of tumour patients.
尽管采用了综合治疗方式,头颈部肿瘤的局部肿瘤复发率仍高达7%至30%。为改善这一数据,光动力疗法(PDT)可作为手术及放化疗之外的一种辅助治疗手段。术中光动力疗法被提议用于在手术切除肿瘤后“清除”肿瘤床,以杀死导致局部肿瘤复发的残留肿瘤细胞。在头颈部手术过程中,大血管和重要神经结构常常暴露在外,术中光动力疗法可能会对其造成潜在损害。尽管间-四(羟基苯基)氯代卟啉(mTHPC)是头颈部肿瘤最常用的光敏剂,但尚无关于术中光动力疗法对这些重要结构潜在有害副作用的数据。本研究的目的是在兔子身上采用最大治疗方案,观察血管和神经结构可能受到的损伤,从而判断在患者身上可能发生的最严重情况。
研究设计/材料与方法:在兔子身上,通过手术暴露颈部和腹股沟区域的大血管和神经结构,并采用mTHPC介导的术中光动力疗法进行治疗。对各种治疗参数(药物-光照间隔、光照剂量、随访间隔)进行调整,以找出可能导致最大组织效应的关键治疗参数。目的是确定mTHPC介导的术中光动力疗法可能引发的最严重临床并发症。
在药物剂量为0.3mg/kg、药物-光照间隔为24小时、光照剂量为20J/cm²时,发现了最严重的组织反应。整个治疗区域内的肌肉、脂肪和结缔组织出现完全坏死。血管表现为严重水肿、中层增生或内皮细胞层疏松,导致不同程度的局部血栓形成,但未发现血管壁破裂或任何破裂情况。大多数神经出现75%的脱髓鞘改变,但未导致任何临床症状。
我们的结果表明,采用最大治疗方案(非常高的剂量和非常短的药物-光照间隔)使用mTHPC介导的术中光动力疗法对所有组织结构具有显著的组织学影响,但在兔子身上未显示出任何临床症状。mTHPC介导的术中光动力疗法似乎是一种有前景且安全的治疗选择,可补充现有治疗方式,以提高肿瘤患者的总生存率。